Possis Medical
AngioJet Xpeedior Catheter
XMI® Thrombectomy Catheters

All the benefits of the XMI catheter in either rapid exchange (RX) or over-the-wire (OTW) for compatibility with today's interventional techniques.

Safe and Effective Thrombus Removal

With over 225,000 cases performed, the AngioJet Thrombectomy System is the proven leader in the safe and effective removal of the thrombus throughout the body. The AngioJet XMI catheter is the only mechanical thrombectomy device approved for use in native coronary arteries and saphenous vein grafts*.

Reduced Complications and Improved Procedure Success
AngioJet Thrombectomy as an adjunct to PCI, has been proven to:
  • Increase procedural success rates†
  • Reduce distal embolization†
  • Lower MACE rates by 50%†
  • Shorten length of stay by one day††
Patented Cross-Stream® technology provides fast and effective 360° thrombus removal  
XMI Features
Compatible with 6F Systems Low profile design allows deliverability and visualization through 6F systems
Tapered Tip Design • Excellent crossability for accessing tight lesions
• Reduced potential for embolization during crossing
Hydrophilic Coating • Ensures smooth delivery and enhanced crossability
• Available on the XMI-RX and XMI-RX+

* XMI-RX+ is indicated for peripheral arterial use only.
† AM ∫ Cardiol 2002; 89(3) 326-330
†† AM Heart ∫ 2001; 142:648-656

The AngioJet System includes several catheter models that are marketed in the U.S. for thrombectomy of coronary arteries and bypass grafts, A.V. access conduits, and peripheral arteries. See product Information for Use for specific and complete prescribing information.

AngioJet, Rheolytic, Cross-Stream, Xpeedior, Tru-Seal, Spiroflex, XMI, AVX, XVG, DVX and Power Pulse are trademarks of Possis Medical, Inc.


1545-001 02 4/07
© Possis 2008  
AngioJet, AVX, Cross-Stream, DVX, Fetch, GuardDOG, Power Pulse, Rheolytic, SafeSeal, Spiroflex, Tru-Seal, XMI, Xpeedior and XVG are trademarks of Possis Medical, Inc.  
home